These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 8701801
21. [Intravesical BCG therapy for superficial bladder cancer]. Segawa N, Iwamoto Y, Azuma H, Yamamoto K, Ueda H, Katsuoka Y. Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666 [Abstract] [Full Text] [Related]
22. [Results and prospects of the combined and complex treatment of cancer of the bladder]. Dunchik VN, Kariakin OB. Vestn Akad Med Nauk SSSR; 1988 Sep; (6):44-50. PubMed ID: 3213197 [No Abstract] [Full Text] [Related]
23. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis. Uchida A, Yonou H, Hayashi E, Iha K, Oda M, Miyazato M, Oshiro Y, Hokama S, Sugaya K, Ogawa Y. Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663 [Abstract] [Full Text] [Related]
28. [Superficial bladder cancer with lung metastasis without local invasion: a case report]. Hirayama T, Matsumoto K, Irie A, Iwamura M, Kudoh O, Iwabuchi K, Ao T, Uchida T, Baba S. Hinyokika Kiyo; 2007 Mar; 53(3):179-82. PubMed ID: 17447488 [Abstract] [Full Text] [Related]
29. Use of Bacillus Calmette-Guerin in superficial bladder cancer: a review. Talug C, Brown ET, Zaslau S, Kandzari SJ. W V Med J; 2009 Mar; 105(3):17-9. PubMed ID: 19456033 [No Abstract] [Full Text] [Related]
32. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association. Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609 [Abstract] [Full Text] [Related]
33. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer. Evans CP. Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082 [No Abstract] [Full Text] [Related]
34. Surgery and intravesical chemotherapy in the management of superficial bladder cancer. Soloway MS. Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424 [No Abstract] [Full Text] [Related]
36. [Survey of instillation methods of BCG in the preventive treatment of superficial tumors of the bladder. Subcommittee of Superficial Tumors of the Bladder, the Committee of Cancerology of the French Association of Urology]. Patard JJ, Chopin D. Prog Urol; 1993 Feb; 3(4):590-4. PubMed ID: 8401619 [Abstract] [Full Text] [Related]